0000877860-26-000135
SEC filingNational Health Investors delivered strong revenue and net income growth in Q1 2026, reflecting continued execution on its real estate investment strategy; however, the pace of earnings expansion moderated relative to top-line growth due to structural shifts in income composition.
We evaluate our business and make resource allocations based on two operating segments: Real Estate Investments and SHOP. This segmentation reflects how management assesses performance and allocates capital, and it anchors our strategic priorities. The growth in revenue and net income for Q1 2026 is attributable to activity across both segments, though the financial packet does not allocate results between them. Our models for estimating future expected credit losses on mortgage and construction loans are calculated on a collective basis, reinforcing that credit risk assessment is integrated across lending activities.
We intend to continue making new investments that meet our underwriting criteria and generate sufficient returns to stockholders on a leverage-neutral basis. Should additional liquidity needs arise, we believe we could access long-term financing in the debt and equity capital markets. This flexibility supports our ability to respond to opportunities without compromising balance sheet discipline. The consistency of operating cash flow, combined with transparent commentary on expense drivers and income composition, provides investors with a grounded view of performance — one rooted in audited financials and corroborated management context, not unsupported attribution or forward-looking speculation.